SÁBADO, 24 NOVEMBRO

Conferência

Anemia na Mulher

16:30 – 17:15

Moderadores

João Mairos e Aurora Belo

Palestrante

Christian Breymann

It is clear that iron-deciency states and anaemia should be treated. Even in milder forms of anaemia, it is often impossible to predict the course of the condition, or whether the situation is likely to worsen, and maternal and foetal risks increase as anaemia becomes more severe. Factors to be taken into account when deciding on the treatment approach to use include the time remaining until delivery, the severity of the anaemia, additional risks (e.g. premature labour), maternal co morbidity and the patient’s own wishes (e.g. refusal to receive donor blood to treat severe anaemia). Thus, for example, a Jehovah’s Witness with severe anaemia two weeks before term needs dierent treatment than a woman with moderate anaemia and no additional risk factors during the second trimester. At present, the main treatment options for anaemia include oral iron, parenteral iron, the stimulation of haemopoiesis with growth factors (e.g. recombinant human erythropoietin) and in rare cases the administration of heterologous blood. However blood transfusion should be avoided whenever possible and principles of patient blood management must be introduced in obstetrics for the mother’s sake.

X